​
​

BioLineRx (BLRX) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

BioLineRx Revenue Highlights

Latest Revenue (Y)

$4.80M

Latest Revenue (Q)

$6.86M

BioLineRx Revenue by Period

BioLineRx Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31--100.00%
2013-12-31--
2012-12-31-77.06%
2011-12-31-100.38%
2010-12-31--

BioLineRx generated $4.80M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

BioLineRx Revenue by Quarter

DateRevenueChange
2024-03-31-42.81%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31--100.00%
2010-12-31--96.84%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31--

BioLineRx generated $6.86M in revenue during Q1 2024, up 42.81% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

BioLineRx Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MCRBSeres Therapeutics--
ARDXArdelyx--
CDTXCidara Therapeutics--
FBIOFortress Biotech--
ARQTArcutis Biotherapeutics--
MREOMereo BioPharma Group--
VRCAVerrica Pharmaceuticals--
BLRXBioLineRx--
LXRXLexicon Pharmaceuticals--
IBRXImmunityBio--
APTOAptose Biosciences--
XFORX4 Pharmaceuticals--
MBIOMustang Bio--
INZYInozyme Pharma--
VRNAVerona Pharma--
LPTXLeap Therapeutics--
TERNTerns Pharmaceuticals--
ACHLAchilles Therapeutics--

BLRX Revenue FAQ

What is BioLineRx’s yearly revenue?

BioLineRx's yearly revenue for 2023 was $4.8M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. BLRX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is BioLineRx’s quarterly revenue?

BioLineRx's quarterly revenue for Q1 2024 was $6.86M, a 42.81% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $4.8M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022). BLRX's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).

What is BioLineRx’s revenue growth rate?

BioLineRx's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.